diroximel fumarate
diroximel fumarate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Vumerity. Available dosage forms: capsule, delayed release, capsule.
Drug Details
- Generic Name
- diroximel fumarate
- Brand Names
- Vumerity
- Application Number
- NDA211855
- Sponsor
- Novo Nordisk Production Ireland Limited
- NDC Codes
- 3
- Dosage Forms
- CAPSULE, DELAYED RELEASE, CAPSULE
- Routes
- ORAL
- Active Ingredients
- DIROXIMEL FUMARATE
Indications and Usage
1 INDICATIONS AND USAGE VUMERITY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. VUMERITY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )